In a landmark study, Johnson & Johnson has announced that ERLEADA (apalutamide) significantly reduces the risk of death by 23% at 24 months compared to enzalutamide in patients with metastatic ...

IRLAB Therapeutics AB has announced the successful completion of the first part of its Phase I clinical trial for IRL757, a drug candidate aimed at treating apathy in patients with Parkinson’s disease ...

Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has approved Yuvanci (macitentan 10 mg and tadalafil 40 mg), a single tablet ...

Oxford Drug Design has been awarded a share of a £3 million Collaborative Discovery Programme (CDP) by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate. This initiative, funded by the ...

In my last article for PharmaTimes about the NHS entitled, ahem, ‘Starmer Times’, I scoped out the challenges facing the NHS for the new leader. It’s depressing as a patient and frustrating as a ...

New government scheme to offer routine opt-out blood tests Starting next week, Sheffield’s Northern General Hospital A&E Department will begin routine opt-out testing for HIV, hepatitis B, and ...

Over the years we have seen significant updates to regulations and guidance across the medical devices, in vitro diagnostic and pharmaceutical sectors. It is clearly well recognised that through the ...

ICON continues to celebrate its achievement at the 2024 Clinical Researcher of the Year Awards, where we were honoured to receive the ‘company of the year’ title in the International PharmaTimes ...

The good folk of medical affairs and nursing have gathered at the opulent Royal Horseguards Hotel for an intoxicating double – the PharmaTimes Medical & Scientific Awards (MSEA) and the Nursing ...

Imagine a world where good is evil and evil is good, where heroes are villains and villains are heroes, where beauty and intelligence are reviled, where the sun is blood red instead of yellow, and ...

Sphere Fluidics has appointed Dr Alex Dickinson to its Board of Directors Sphere Fluidics has announced the appointment of Dr Alex Dickinson to its Board of Directors as a Non-Executive Director (NED) ...

The era of equity – or striving for it – is not about rewriting history. Nor is it about righting history’s myriad wrongs. History has happened. History is toast. History is, erm, history – in the ...